U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07736404) titled 'A Study of SYH2082 Injection in Healthy Participants' on July 14.

Brief Summary: To evaluate the safety and tolerability of single dose of SYH2082 Injection in healthy participants.

Study Start Date: April 13

Study Type: INTERVENTIONAL

Condition: Overweight or Obesity

Intervention: DRUG: SYH2082 Injection

A subcutaneous injection in the abdomen of the corresponding dose of SYH2082 Injection according to the assigned dose cohort.

DRUG: Placebo

A subcutaneous injection in the abdomen of the corresponding dose of Placebo according to the assigned dose cohort.

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: CSPC Ouyi Pharm...